Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • PRESCRIPTION DRUGS—FINAL RULES: CMS locks in Medicare drug negotiation rules for 2029 and beyond
    • AUDITS AND MONITORING—OIG REPORTS: HRSA made an estimated $658 Million in Phase 3 Provider Relief Fund potential overpayments
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—What compounding pharmacies need to know about the HHS interim enforcement discretion policy for six peptides
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HEALTH CARE EMPLOYMENT ISSUES—D. Md.: EMT’s claim that he was terminated in retaliation for protected conduct dismissed
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HOME HEALTH—FINAL RULES: CMS paired home health payment increase with broader Medicare integrity controls
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: FDA classifies prognostic assessment software
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PHYSICIAN FEE SCHEDULE—FINAL RULES: CMS recalibrated physician payments to favor coordinated care and curb duplicative spending
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • STATE LEGISLATION NEWS—Health Care Group Settles With Four States Over Data Breach
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • WORTH NOTING—Other Health Law litigation and regulatory developments
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS—What compounding pharmacies need to know about the HHS interim enforcement discretion policy for six peptides, (Nov 9, 2026)

    Law Firms Mentioned:Buchanan Ingersoll & Rooney PC

    By Lucas Morgan, Dae Lee and Emily A. Carey of Buchanan Ingersoll & Rooney PC

    The U.S. Department of Health and Human Services (HHS) has announced an interim enforcement discretion policy addressing the compounding of six peptide bulk drug substances while the FDA continues to consider their status under Section 503A of the Fe ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use